Study to Evaluate the Pharmacokinetics of Oral Sparsentan Suspension

NCT05562362 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: RE-021, sparsentan

Sponsor

Travere Therapeutics, Inc.